Details

Autor(en) / Beteiligte

• Ko, J.-H.
• Peck, K. R.
• Lee, W. J.
• Huh, K.
• Yoo, J. R.
• Kim, K.
• Cho, S. Y.
• Ha, Y. E.
• Kang, C.-I.
• Chung, D. R.
• Jung, C. W.
• Kim, Y.-H.
• Lee, N. Y.
• Kim, K.-M.
• Song, J.-H.

Titel

Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancer

Ist Teil von

• European journal of clinical microbiology & infectious diseases, 2014-10, Vol.33 (10), p.1847-1853

Ort / Verlag

Berlin/Heidelberg: Springer Berlin Heidelberg

Erscheinungsjahr

2014

Quelle

MEDLINE

Beschreibungen/Notizen

• Cytomegalovirus (CMV) gastrointestinal (GI) disease has been noticed frequently in cancer patients, causing abdominal pain, diarrhea, and GI bleeding. However, little is known about its actual incidence, clinical presentation, and the risk factors for its development among cancer patients. To answer these questions, we analyzed all cases that occurred during an 18-year period at our center. A case–control study was performed to identify risk factors for CMV GI disease. Electronic medical records were reviewed from individuals who were admitted and diagnosed with CMV GI disease during the period of January 1995 through March 2013 at a tertiary care center. Two CMV disease-free cancer patients were matched as controls. A total of 98 episodes of CMV GI disease were included in this study, and the overall incidence rate was 52.5 per 100,000 cancer patients, with an increasing trend throughout the study period. According to multivariate analysis, male sex, low body mass index, lymphopenia, hematological malignancy, and steroid use and red blood cell transfusion within 1 month prior to the CMV disease were identified to be independent risk factors. Among these factors, RBC transfusion showed the highest odds ratio (OR = 5.09). Male sex, low body mass index, lymphopenia, hematological malignancy, steroid use, and red blood cell transfusion within 1 month prior to the CMV disease diagnosis were independent risk factors for the development of CMV GI disease in adult patients with cancer.